GB BPR Efficacy Claims: What Evidence a Disinfectant Claim Needs and What a Website May Say

Efficacy is a condition of authorisation, not a marketing choice

GB BPR requires that a biocidal product be shown to be sufficiently effective for its intended use before it can be authorised, alongside acceptable risks to people, animals and the environment. HSE's guidance on efficacy information requirements (Volume II Part A) sets out what an applicant must supply: the function of the product, the target organisms, the field of use, the mode of application, the dose rate and contact time, and efficacy data supporting each claim, including laboratory tests, simulated-use tests and where relevant field trials. HSE's assessment guidance (Volume II Parts B and C) then describes how those data are evaluated against acceptance criteria for the product type.

The practical meaning is that a claim is only as good as the data behind it and the conditions under which those data were generated. A product tested to a bactericidal standard under clean conditions at a given concentration and contact time has evidence for that claim under those conditions. It does not, by that test alone, have evidence for a shorter contact time, a dirtier surface, a different organism group or a different field of use. Claims of yeasticidal, fungicidal, virucidal, sporicidal or biofilm activity each require their own supporting tests.

How the European test standards feed into claims

For disinfectants the evidence base is normally built from the EN standard series: phase 1 suspension tests that show basic activity (for example EN 1040 for bacteria), phase 2 step 1 quantitative suspension tests under conditions representative of the field (EN 1276 and EN 13727 for bacteria, EN 1650 and EN 13624 for yeasts and fungi, EN 14476 for viruses), and phase 2 step 2 surface or carrier tests (EN 13697, EN 16615, EN 14561 and related standards) that expose the product to a dried inoculum on a surface. Each standard specifies the organisms, soiling, temperature, contact time and the log reduction needed to pass. Water-treatment product types such as PT2 pool water, PT5 drinking water and PT11 cooling water are assessed against the relevant guidance for the use rather than surface standards alone.

A published pass against a standard supports the specific wording that standard underwrites. 'Bactericidal according to EN 1276 at X ppm and Y minutes under dirty conditions' is a defensible claim; 'kills 99.99% of all bacteria' is not, because the standard tested named strains under defined conditions and the reduction criterion of the standard (5 log for EN 1276) is not a statement about every organism everywhere. Independent studies of chlorine dioxide in general, however rigorous, are evidence about chlorine dioxide under the tested conditions and are not efficacy data for a specific product unless generated on that product.

Advertising: mandatory wording and prohibited terms

HSE's advertising guidance applies GB BPR (and EU BPR in Northern Ireland) to any means of promoting the sale or use of a biocidal product, which includes websites and social media. Two rules matter most. First, every advertisement must carry the sentences 'Use biocides safely. Always read the label and product information before use', clearly distinguishable and legible; the word 'biocides' may be replaced with the product type, so 'Use disinfectants safely' is acceptable. Second, an advertisement must not describe the product in a way that is misleading about its risks to human or animal health, its risks to the environment, or its efficacy. HSE lists terms that are treated as misleading and must not be used: 'low-risk', 'non-toxic', 'harmless', 'natural', 'environmentally friendly', 'animal friendly' and any similar wording. HSE does not endorse products, so phrases such as 'HSE approved' are also prohibited. These advertising rules are enforced by Trading Standards rather than by HSE.

The efficacy limb is the one most often breached inadvertently. HSE does not ban particular words, but wording such as 'eliminates', 'eradicates', 'total', 'all', 'guaranteed' or an unqualified 'proven' readily extends a claim beyond the conditions in which it was tested, and that is what makes it misleading. Case-study results are real observations from one site and should be presented as such, with the sampling method and timeframe, not restated as a general performance promise. Comparative claims against other chemistries should rest on comparable data. Claims about organisms that regulators treat as resistant to a chemistry, such as Cryptosporidium for chlorine and chlorine dioxide in private water supplies, must follow the regulator's position rather than a favourable study.

How ChloroKlean applies this to its own website

ChloroKlean products are supplied for the Great Britain market under GB BPR for the product types stated on each product page, using transitional arrangements while the relevant in-situ chlorine dioxide active-substance routes complete the GB Review Programme; no EU or Northern Ireland authorisation is claimed. The required 'Use biocides safely. Always read the label and product information before use' sentence is carried in the footer of every page of this website as well as on product pages, and our copy is reviewed against the HSE list of misleading terms.

On efficacy we distinguish three kinds of statement. Test results are tied to the standard, concentration, contact time and conditions under which they were obtained. Case-study results are described as what was observed at that site with the monitoring used, for example 'no Legionella detected in routine sampling over twelve months', not as elimination or eradication. Published research about chlorine dioxide, which forms the basis of the Learn library, is presented as evidence about the chemistry under the study's conditions and is explicitly not presented as evidence for any ChloroKlean product. Where earlier copy on this site used broader wording, it is being tightened to this standard. Chlorine dioxide's own by-products, chlorite and chlorate, are described accurately rather than the product being called by-product-free.

A checklist for reviewing a disinfectant claim

Ask: which product, at what concentration and contact time, against which organisms, under which soiling and temperature, tested to which standard, generated by whom, and is the product authorised or compliant for the field of use in which the claim is being made? If any element is missing, the claim should be narrowed until every element is present. If the evidence is a third-party study on chlorine dioxide rather than on the product, say so. If the evidence is a case study, describe the observation and its limits. If the wording touches risk ('safe', 'gentle', 'eco'), check it against the HSE prohibited list and the product's classification and labelling.

Evidence and uncertainty

Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.

For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.

Choosing the next question

A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.

Where a product is considered, confirm the intended use, authorisation and label directions independently of this educational guide.

Use this sequence to frame investigation and control; it is not a dosing protocol.

Expert Insights

About the Reviewer

Frequently Asked Questions

Common questions about this topic, answered by our technical team.

Related Resources

Continue exploring our knowledge base and product information.